Blog

Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

By ZappRx on January 05, 2016

If you work in the pharma or biotech industry, you’ve probably heard the buzz about biosimilars. And, there’s a good...

Read More
The dangerous delay in treating epilepsy patients

The dangerous delay in treating epilepsy patients

By ZappRx on November 02, 2015

Imagine a mother, sitting in her living room, frantically calling a pharmacy, wondering why her son’s epilepsy...

Read More
Page 1 of 1
1